 Kristen Boyle
Concepts (204)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Obesity | 19 | 2023 | 2508 | 2.430 |
Why?
| | Fatty Acids | 6 | 2021 | 381 | 1.710 |
Why?
| | Lipid Metabolism | 9 | 2023 | 444 | 1.340 |
Why?
| | DNA Methylation | 5 | 2023 | 495 | 1.330 |
Why?
| | Adiposity | 8 | 2023 | 458 | 1.330 |
Why?
| | Muscle, Skeletal | 8 | 2017 | 1473 | 1.170 |
Why?
| | Pediatric Obesity | 4 | 2023 | 488 | 1.110 |
Why?
| | Pregnancy Complications | 2 | 2021 | 429 | 0.920 |
Why?
| | Circadian Clocks | 1 | 2023 | 42 | 0.870 |
Why?
| | Pregnancy | 18 | 2023 | 5518 | 0.860 |
Why?
| | Adipogenesis | 3 | 2023 | 42 | 0.850 |
Why?
| | Mitochondrial Proteins | 3 | 2014 | 219 | 0.820 |
Why?
| | Infant, Newborn | 10 | 2023 | 5047 | 0.760 |
Why?
| | Prenatal Exposure Delayed Effects | 3 | 2023 | 452 | 0.760 |
Why?
| | Mitochondria | 7 | 2022 | 747 | 0.720 |
Why?
| | Diabetes, Gestational | 2 | 2014 | 281 | 0.680 |
Why?
| | Mothers | 2 | 2023 | 651 | 0.680 |
Why?
| | Fatty Acid Desaturases | 1 | 2020 | 29 | 0.670 |
Why?
| | Transgenes | 1 | 2020 | 170 | 0.650 |
Why?
| | Diet, High-Fat | 2 | 2020 | 225 | 0.650 |
Why?
| | Spectrophotometry | 1 | 2019 | 48 | 0.640 |
Why?
| | Electron Transport Complex I | 1 | 2019 | 33 | 0.630 |
Why?
| | Maternal Exposure | 1 | 2020 | 138 | 0.620 |
Why?
| | Enzymes | 1 | 2019 | 62 | 0.610 |
Why?
| | Oxidation-Reduction | 9 | 2021 | 923 | 0.600 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2020 | 172 | 0.600 |
Why?
| | Caenorhabditis elegans Proteins | 1 | 2020 | 180 | 0.590 |
Why?
| | Oxidative Stress | 3 | 2020 | 1076 | 0.570 |
Why?
| | Fenofibrate | 1 | 2016 | 24 | 0.530 |
Why?
| | Glycogen Synthase Kinase 3 | 1 | 2015 | 77 | 0.500 |
Why?
| | PPAR gamma | 2 | 2016 | 182 | 0.500 |
Why?
| | Dietary Fats | 3 | 2010 | 287 | 0.460 |
Why?
| | beta Catenin | 1 | 2015 | 219 | 0.450 |
Why?
| | Female | 25 | 2023 | 59507 | 0.440 |
Why?
| | Muscle Development | 3 | 2021 | 98 | 0.440 |
Why?
| | Electron Transport Complex II | 1 | 2013 | 23 | 0.440 |
Why?
| | Insulin | 8 | 2022 | 2079 | 0.420 |
Why?
| | Placenta | 4 | 2023 | 626 | 0.420 |
Why?
| | Sirtuin 3 | 1 | 2013 | 52 | 0.420 |
Why?
| | Muscle Proteins | 1 | 2014 | 210 | 0.420 |
Why?
| | Calcium Signaling | 1 | 2014 | 217 | 0.410 |
Why?
| | DNA, Mitochondrial | 2 | 2022 | 182 | 0.400 |
Why?
| | Umbilical Cord | 3 | 2017 | 80 | 0.390 |
Why?
| | Infant | 8 | 2023 | 7963 | 0.390 |
Why?
| | Superoxide Dismutase | 1 | 2013 | 306 | 0.380 |
Why?
| | Muscle Fibers, Skeletal | 3 | 2011 | 185 | 0.380 |
Why?
| | Glucose | 3 | 2023 | 897 | 0.380 |
Why?
| | Lipid Peroxidation | 1 | 2011 | 139 | 0.380 |
Why?
| | Fluorocarbons | 2 | 2023 | 94 | 0.360 |
Why?
| | Environmental Pollutants | 2 | 2023 | 110 | 0.360 |
Why?
| | Birth Weight | 3 | 2023 | 440 | 0.360 |
Why?
| | Electron Transport | 4 | 2019 | 108 | 0.330 |
Why?
| | Humans | 33 | 2023 | 114686 | 0.320 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2022 | 151 | 0.280 |
Why?
| | Body Mass Index | 6 | 2023 | 1959 | 0.260 |
Why?
| | Insulin, Regular, Human | 2 | 2022 | 33 | 0.250 |
Why?
| | Fetal Blood | 2 | 2023 | 270 | 0.230 |
Why?
| | ARNTL Transcription Factors | 1 | 2023 | 13 | 0.230 |
Why?
| | Caprylates | 1 | 2023 | 19 | 0.220 |
Why?
| | Hypertrophy | 1 | 2023 | 109 | 0.210 |
Why?
| | Cells, Cultured | 3 | 2016 | 3886 | 0.210 |
Why?
| | Cell Differentiation | 2 | 2023 | 1701 | 0.210 |
Why?
| | Triglycerides | 2 | 2023 | 467 | 0.210 |
Why?
| | Allostasis | 1 | 2022 | 12 | 0.200 |
Why?
| | Obesity, Metabolically Benign | 1 | 2021 | 4 | 0.200 |
Why?
| | Pregnancy Proteins | 1 | 2022 | 36 | 0.190 |
Why?
| | Adipocytes | 1 | 2023 | 188 | 0.190 |
Why?
| | Male | 16 | 2023 | 55596 | 0.190 |
Why?
| | Metabolic Flux Analysis | 1 | 2021 | 7 | 0.190 |
Why?
| | Fasting | 1 | 2023 | 240 | 0.190 |
Why?
| | 11-beta-Hydroxysteroid Dehydrogenase Type 2 | 1 | 2021 | 9 | 0.180 |
Why?
| | Mitogen-Activated Protein Kinase 9 | 1 | 2021 | 18 | 0.180 |
Why?
| | Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2021 | 42 | 0.180 |
Why?
| | Young Adult | 6 | 2017 | 10469 | 0.180 |
Why?
| | Adult | 11 | 2022 | 30550 | 0.180 |
Why?
| | Premature Birth | 1 | 2023 | 276 | 0.180 |
Why?
| | Metabolic Networks and Pathways | 1 | 2021 | 168 | 0.170 |
Why?
| | Carnitine O-Palmitoyltransferase | 2 | 2017 | 43 | 0.170 |
Why?
| | Precision Medicine | 1 | 2023 | 337 | 0.170 |
Why?
| | p38 Mitogen-Activated Protein Kinases | 1 | 2021 | 260 | 0.170 |
Why?
| | Child | 6 | 2023 | 18414 | 0.170 |
Why?
| | Pilot Projects | 1 | 2023 | 1373 | 0.160 |
Why?
| | Aconitate Hydratase | 1 | 2019 | 16 | 0.160 |
Why?
| | Autism Spectrum Disorder | 1 | 2023 | 322 | 0.160 |
Why?
| | Child, Preschool | 5 | 2023 | 9116 | 0.160 |
Why?
| | Animals | 6 | 2023 | 31706 | 0.160 |
Why?
| | Gene Expression | 1 | 2023 | 1421 | 0.160 |
Why?
| | Insulin-Like Growth Factor I | 1 | 2021 | 286 | 0.160 |
Why?
| | Carnitine | 3 | 2017 | 62 | 0.160 |
Why?
| | Phosphorylation | 3 | 2021 | 1569 | 0.150 |
Why?
| | Metabolic Syndrome | 1 | 2021 | 321 | 0.150 |
Why?
| | Acetyl-CoA Carboxylase | 1 | 2017 | 33 | 0.150 |
Why?
| | Environmental Exposure | 1 | 2020 | 372 | 0.140 |
Why?
| | Caenorhabditis elegans | 1 | 2020 | 268 | 0.140 |
Why?
| | Mice, Transgenic | 2 | 2020 | 1949 | 0.130 |
Why?
| | Longitudinal Studies | 3 | 2020 | 2387 | 0.130 |
Why?
| | Niacinamide | 1 | 2016 | 63 | 0.130 |
Why?
| | Glycogen Synthase Kinase 3 beta | 1 | 2015 | 60 | 0.130 |
Why?
| | Transcription Factors | 1 | 2023 | 1528 | 0.130 |
Why?
| | Diabetes Mellitus | 1 | 2023 | 900 | 0.130 |
Why?
| | Glucose Tolerance Test | 2 | 2014 | 343 | 0.130 |
Why?
| | Exercise Tolerance | 1 | 2017 | 213 | 0.120 |
Why?
| | Amino Acids | 2 | 2017 | 448 | 0.120 |
Why?
| | Fluorodeoxyglucose F18 | 1 | 2015 | 113 | 0.120 |
Why?
| | Adenylate Kinase | 1 | 2014 | 26 | 0.120 |
Why?
| | Glutathione | 2 | 2013 | 293 | 0.120 |
Why?
| | Metabolome | 1 | 2017 | 282 | 0.110 |
Why?
| | Insulin Resistance | 3 | 2011 | 1072 | 0.110 |
Why?
| | Prediabetic State | 1 | 2016 | 219 | 0.110 |
Why?
| | Gene Expression Regulation, Developmental | 1 | 2017 | 801 | 0.100 |
Why?
| | Interleukin-1 | 1 | 2017 | 966 | 0.100 |
Why?
| | Cardiovascular Diseases | 1 | 2023 | 1727 | 0.100 |
Why?
| | Membrane Proteins | 1 | 2017 | 1019 | 0.100 |
Why?
| | Uncoupling Protein 3 | 1 | 2010 | 10 | 0.090 |
Why?
| | Pyruvate Dehydrogenase (Lipoamide) | 1 | 2010 | 3 | 0.090 |
Why?
| | Signal Transduction | 2 | 2022 | 4513 | 0.090 |
Why?
| | PPAR alpha | 1 | 2010 | 52 | 0.090 |
Why?
| | Inflammation | 2 | 2022 | 2480 | 0.090 |
Why?
| | Lipolysis | 1 | 2010 | 39 | 0.090 |
Why?
| | Ion Channels | 1 | 2010 | 123 | 0.090 |
Why?
| | Metabolomics | 1 | 2015 | 521 | 0.090 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2010 | 162 | 0.090 |
Why?
| | Subcutaneous Fat | 1 | 2010 | 70 | 0.090 |
Why?
| | Diet | 2 | 2022 | 1080 | 0.080 |
Why?
| | Mice | 4 | 2020 | 14869 | 0.080 |
Why?
| | Epigenesis, Genetic | 2 | 2023 | 520 | 0.080 |
Why?
| | Energy Metabolism | 3 | 2022 | 731 | 0.080 |
Why?
| | Rodentia | 1 | 2009 | 44 | 0.080 |
Why?
| | Proteomics | 1 | 2014 | 836 | 0.080 |
Why?
| | Myostatin | 1 | 2008 | 26 | 0.080 |
Why?
| | TOR Serine-Threonine Kinases | 2 | 2022 | 358 | 0.080 |
Why?
| | Prostatic Neoplasms | 1 | 2015 | 921 | 0.080 |
Why?
| | Adolescent | 4 | 2016 | 17844 | 0.080 |
Why?
| | Hydrogen Peroxide | 1 | 2009 | 288 | 0.070 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2320 | 0.070 |
Why?
| | Cohort Studies | 1 | 2015 | 4895 | 0.060 |
Why?
| | Exercise | 2 | 2022 | 1644 | 0.060 |
Why?
| | Obesity, Morbid | 1 | 2008 | 197 | 0.060 |
Why?
| | Blood Glucose | 2 | 2010 | 1828 | 0.060 |
Why?
| | Cell Proliferation | 1 | 2011 | 2187 | 0.060 |
Why?
| | RNA, Messenger | 1 | 2010 | 2553 | 0.050 |
Why?
| | Weight Loss | 1 | 2008 | 642 | 0.050 |
Why?
| | Biomarkers | 3 | 2020 | 3408 | 0.050 |
Why?
| | Bayes Theorem | 1 | 2023 | 329 | 0.050 |
Why?
| | Consensus | 1 | 2023 | 537 | 0.050 |
Why?
| | Gestational Age | 1 | 2023 | 760 | 0.050 |
Why?
| | Skinfold Thickness | 1 | 2020 | 49 | 0.040 |
Why?
| | Leukocytes, Mononuclear | 1 | 2022 | 493 | 0.040 |
Why?
| | Endoplasmic Reticulum Stress | 1 | 2020 | 91 | 0.040 |
Why?
| | Evidence-Based Medicine | 1 | 2023 | 668 | 0.040 |
Why?
| | Colorado | 2 | 2020 | 4099 | 0.040 |
Why?
| | Sex Characteristics | 1 | 2023 | 640 | 0.040 |
Why?
| | In Vitro Techniques | 1 | 2021 | 1016 | 0.040 |
Why?
| | Middle Aged | 2 | 2016 | 26737 | 0.040 |
Why?
| | Aged | 1 | 2016 | 19074 | 0.040 |
Why?
| | Stem Cells | 1 | 2022 | 546 | 0.040 |
Why?
| | Muscle Cells | 1 | 2017 | 42 | 0.040 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 17 | 0.040 |
Why?
| | Mitochondrial Diseases | 1 | 2017 | 77 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 74 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 76 | 0.030 |
Why?
| | Sirtuin 1 | 1 | 2016 | 29 | 0.030 |
Why?
| | Oxidative Phosphorylation | 1 | 2017 | 155 | 0.030 |
Why?
| | Plethysmography | 1 | 2016 | 103 | 0.030 |
Why?
| | Maternal Nutritional Physiological Phenomena | 1 | 2017 | 141 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 228 | 0.030 |
Why?
| | Epoxy Compounds | 1 | 2015 | 31 | 0.030 |
Why?
| | Heterografts | 1 | 2015 | 117 | 0.030 |
Why?
| | Physical Conditioning, Animal | 1 | 2017 | 194 | 0.030 |
Why?
| | Running | 1 | 2017 | 207 | 0.030 |
Why?
| | Postprandial Period | 1 | 2015 | 87 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 544 | 0.030 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 4694 | 0.030 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2016 | 797 | 0.030 |
Why?
| | Positron-Emission Tomography | 1 | 2015 | 259 | 0.030 |
Why?
| | Lipids | 1 | 2017 | 580 | 0.030 |
Why?
| | Mice, Nude | 1 | 2015 | 630 | 0.030 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1230 | 0.030 |
Why?
| | Lipopolysaccharides | 1 | 2017 | 823 | 0.030 |
Why?
| | Polymerase Chain Reaction | 1 | 2016 | 993 | 0.030 |
Why?
| | Prospective Studies | 1 | 2023 | 6220 | 0.030 |
Why?
| | Cell Line | 1 | 2017 | 2637 | 0.020 |
Why?
| | Microdialysis | 1 | 2010 | 49 | 0.020 |
Why?
| | Glycerol | 1 | 2010 | 84 | 0.020 |
Why?
| | Cholesterol, HDL | 1 | 2010 | 183 | 0.020 |
Why?
| | Glutathione Disulfide | 1 | 2009 | 26 | 0.020 |
Why?
| | Cholesterol | 1 | 2010 | 367 | 0.020 |
Why?
| | Catalase | 1 | 2009 | 118 | 0.020 |
Why?
| | Adenosine Diphosphate | 1 | 2009 | 81 | 0.020 |
Why?
| | Cell Line, Tumor | 1 | 2015 | 2710 | 0.020 |
Why?
| | Risk Factors | 1 | 2021 | 8632 | 0.020 |
Why?
| | Glucose Clamp Technique | 1 | 2009 | 181 | 0.020 |
Why?
| | Immunoblotting | 1 | 2008 | 283 | 0.020 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1013 | 0.020 |
Why?
| | Oligopeptides | 1 | 2009 | 236 | 0.020 |
Why?
| | Chromatography, Liquid | 1 | 2008 | 347 | 0.020 |
Why?
| | Gastric Bypass | 1 | 2008 | 92 | 0.020 |
Why?
| | Tandem Mass Spectrometry | 1 | 2008 | 411 | 0.020 |
Why?
| | Oxygen Consumption | 1 | 2009 | 588 | 0.020 |
Why?
| | Antioxidants | 1 | 2009 | 530 | 0.020 |
Why?
| | Rats, Sprague-Dawley | 1 | 2009 | 2218 | 0.010 |
Why?
| | Body Weight | 1 | 2008 | 869 | 0.010 |
Why?
| | Rats | 1 | 2009 | 4958 | 0.010 |
Why?
| | Cross-Sectional Studies | 1 | 2008 | 4409 | 0.010 |
Why?
|
|
Boyle's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|